Robeco Institutional Asset Management B.V. Catalent, Inc. Transaction History
Robeco Institutional Asset Management B.V.
- $49.7 Billion
- Q3 2024
A detailed history of Robeco Institutional Asset Management B.V. transactions in Catalent, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 4,068 shares of CTLT stock, worth $247,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,068
Previous 4,068
-0.0%
Holding current value
$247,131
Previous $228,000
7.89%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding CTLT
# of Institutions
514Shares Held
149MCall Options Held
575KPut Options Held
2.03M-
Vanguard Group Inc Valley Forge, PA20.2MShares$1.23 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY15.4MShares$933 Million0.02% of portfolio
-
State Street Corp Boston, MA7.45MShares$453 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA6.4MShares$389 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.52MShares$274 Million0.14% of portfolio
About Catalent, Inc.
- Ticker CTLT
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 179,896,000
- Market Cap $10.9B
- Description
- Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...